CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 


<
Abbott Laboratories  (ABT)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 



 

Abbott Laboratories

ABT's Financial Statements and Analysis






Abbott Laboratories reported IV. Quarter net loss per share of $-0.48 compare to earnings per share of $0.54 in the same quarter a year ago a decrease from $0.34 eps realized in III. Quarter (Sep 30 2017).

Abbott Laboratories's Revenue rose by % in IV. Quarter (Dec 31 2017) year on year, to $7,589 million and advanced by 11.13 % sequentially.


Abbott Laboratories is
More on ABT's Income Statement

IV. Quarter
Earnings Per Share Revenues
$ -0.48 $  7,589 Mill
$-1.02     $+2,256M     +42.3 %
You need to upgrade your Flash Player


       
  • Established Pharmaceutical Products 24.64% Y/Y,
• Pediatric Nutritionals 3.95% Y/Y,
• Nutritionals 0.11% Y/Y
   
     
       
  • Adult Nutritionals -1.92% Y/Y,
• Endovascular -0.77% Y/Y,
• Vascular -7.95% Y/Y,
• Diagnostics -2.03% Y/Y,
• Other -10.06% Y/Y
   
     


ABT's Segments

ABT's NET INCOME

Abbott Laboratories's in IV. Quarter recorded net loss of $-828 million, compare to net income of $798 million achieved in IV. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $603.00 million in previous quarter.

More on ABT's Growth

Abbott Laboratories Income Growth by Division

• Vascular -14.64% Y/Y,
• Diagnostics -0.97% Y/Y • Established Pharmaceutical Products 10.63% Y/Y,
• Nutritionals 24.39% Y/Y

Inventories Inventories grew by 47.95 % to $3,601 million from IV. Quarter a year ago, sequentially inventories rose by 3.39 %. In IV. Quarter company's net cash and cash equivalents decreased by $-1,605 million, capital expenditures fell by 8.15%, to $-345 millions compare to same quarter a year ago and fell by 31.18% from III. Quarter (Sep 30 2017).

More on ABT's Cash flow Statement



Abbott Laboratories payed out dividend of $1.06 per share in last 52 weeks representing 407.69 % of net earning per share in trailing twelve-month period.

During the same period Abbott Laboratories earned $ 3.17 cash per share, on a free-cash flow basis 1218.77 % of net earning per share.

Book value fell by -3.67 % sequentially to $17.69 per share.
Tangible Book value fell to $ -8.19 per share from $ -4.80.

Company issued 3.61 million shares or 0.21 % in IV. Quarter.
Interest Coverage Ratio was 3.47. Debt Coverage Ratio was 0.13.

More on ABT's Dividends
 Market Capitalization (Millions) 102,495
 Shares Outstanding (Millions) 1,758
 Total Debt (Millions $) 27,924
 Revenue (TTM) (Millions $) 27,390
 Net Income (TTM) (Millions $) 477
 Cash Flow (TTM) (Millions $) -9,213
 Capital Exp. (TTM) (Millions $) -1,135
 Dividend TTM ($) 1.06 $
 Dividend Yield TTM (%) 1.82 %
 Employees (TTM) $ 77,000





Abbott Laboratories payed out dividend of $1.06 per share in last 52 weeks representing 407.69 % of net earning per share in trailing twelve-month period.

During the same period Abbott Laboratories earned $ 3.17 cash per share, on a free-cash flow basis 1218.77 % of net earning per share.

Book value fell by -3.67 % sequentially to $17.69 per share.
Tangible Book value fell to $ -8.19 per share from $ -4.80.

Company issued 3.61 million shares or 0.21 % in IV. Quarter.
Interest Coverage Ratio was 3.47. Debt Coverage Ratio was 0.13.

More on ABT's Dividends
 Market Capitalization (Millions) 102,495
 Shares Outstanding (Millions) 1,758
 Total Debt (Millions $) 27,924
 Revenue (TTM) (Millions $) 27,390
 Net Income (TTM) (Millions $) 477
 Cash Flow (TTM) (Millions $) -9,213
 Capital Exp. (TTM) (Millions $) -1,135
 Dividend TTM ($) 1.06 $
 Dividend Yield TTM (%) 1.82 %
 Employees (TTM) $ 77,000


   

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HCRE's Profile

Stock Price

HCRE's Financials

Business Description

Fundamentals

Charts & Quotes

HCRE's News

Suppliers

HCRE's Competitors

Customers & Markets

Economic Indicators

HCRE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071